Jeffrey S. Glenn, Director at Eiger BioPharmaceuticals, Inc. (EIGR), bought 100,000 shares at $1.28 ($128K) on 2022-12-22, disclosed to the SEC on 2022-12-27.
Open-market purchase of $128k EIGR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| EIGR | BUY | 2017-09-05 | $143K | — | Filing → |
| EIGR | BUY | 2016-11-21 | $197K | — | Filing → |